Valuation: Xvivo Perfusion AB

Market Cap 8.86B 919M 804M 741M 685M 1.3B 87.64B 1.32B 3.48B 43.17B 3.45B 3.37B 148B P/E 2026 *
80.3x
P/E 2027 * 44.3x
Enterprise Value 8.71B 904M 791M 729M 674M 1.28B 86.22B 1.3B 3.42B 42.48B 3.39B 3.32B 146B EV / Sales 2026 *
8.83x
EV / Sales 2027 * 6.83x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-0.92%
1 week+0.43%
Current month+8.32%
1 month+5.32%
3 months+6.52%
6 months+44.28%
Current year+50.70%
1 week 274.4
Extreme 274.4
288.2
1 month 242.2
Extreme 242.2
288.2
Current year 171.8
Extreme 171.8
310.4
1 year 160
Extreme 160
310.4
3 years 160
Extreme 160
547
5 years 127.8
Extreme 127.8
547
10 years 67
Extreme 67
547
Manager TitleAgeSince
Chief Executive Officer 51 2022-09-26
Director of Finance/CFO 41 2020-11-30
Chief Operating Officer 61 2022-11-30
Director TitleAgeSince
Chairman 67 2018-04-26
Director/Board Member 62 2016-04-30
Director/Board Member 65 2021-12-31
Date Insider Type Main position Quantity % Market Cap.
Mar. 19Buy

Chief Financial Officer

300 0.0010%
Dec. 03Buy

Chief Financial Officer

250 0.0008%
Dec. 03Buy

Chief Financial Officer

250 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%+0.43%+39.62%-11.57% 919M
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.42%-0.88%+8.17%-1.13% 53.42B
Weighted average by Cap. +0.50%-0.93%-5.52%+1.00%

Financials

2026 *2027 *
Net sales 987M 102M 89.56M 82.61M 76.29M 145M 9.77B 147M 388M 4.81B 384M 376M 16.54B 1.27B 132M 115M 107M 98.37M 187M 12.59B 190M 500M 6.2B 496M 485M 21.32B
Net income 110M 11.45M 10.02M 9.24M 8.53M 16.19M 1.09B 16.46M 43.35M 538M 42.99M 42.06M 1.85B 200M 20.76M 18.16M 16.75M 15.47M 29.35M 1.98B 29.85M 78.59M 975M 77.95M 76.25M 3.35B
Net Debt -143M -14.83M -12.97M -11.96M -11.05M -20.97M -1.41B -21.32M -56.14M -697M -55.68M -54.47M -2.4B -162M -16.86M -14.74M -13.6M -12.56M -23.83M -1.61B -24.23M -63.81M -792M -63.29M -61.91M -2.72B
Logo Xvivo Perfusion AB
Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The Company markets its products in Europe, Asia, Middle East, and North & South America.
Employees
199
Date Price Change Volume
26-07-10 SEK 281.20 -0.92% 38,260
26-07-09 SEK 283.80 +3.05% 38,774
26-07-08 SEK 275.40 -2.20% 35,986
26-07-07 SEK 281.60 -0.85% 26,044
26-07-06 SEK 284.00 +1.43% 32,071
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
281.20SEK
Average target price
347.40SEK
Spread / Average Target
+23.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. XVIVO Stock